Seeking Alpha

Merck (MRK -0.4%) says it will acquire Inspire Pharmaceuticals (ISPH), a developer of ophthalmic...

Merck (MRK -0.4%) says it will acquire Inspire Pharmaceuticals (ISPH), a developer of ophthalmic products, in an all-cash deal for $5/share, or ~$430M. The offer represents a 26% premium to yesterday's closing price. Trading in ISPH halted. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)